Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's …
HH Hansen, K Fabricius, P Barkholt, JD Mikkelsen… - Brain research, 2016 - Elsevier
Abstract Exendin-4, a glucagon-like peptide-1 (GLP-1) receptor agonist, have been
demonstrated to promote neuroprotection in the rat 6-hydroxydopamine (6-OHDA)
neurotoxin model of Parkinson's disease (PD), a neurodegenerative disorder characterized …
demonstrated to promote neuroprotection in the rat 6-hydroxydopamine (6-OHDA)
neurotoxin model of Parkinson's disease (PD), a neurodegenerative disorder characterized …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论